Neuroimaging and clinical outcomes of oral
anticoagulant-associated intracerebral hemorrhage

J 2018

Neuroimaging and clinical outcomes of oral anticoagulant-associated intracerebral hemorrhage

TSIVGOULIS, Georgios; Duncan WILSON; Aristeidis H. KATSANOS; Joao SARGENTO-FREITAS; Claudia MARQUES-MATOS et. al.

Základní údaje

Originální název

Neuroimaging and clinical outcomes of oral anticoagulant-associated intracerebral hemorrhage

Autoři

TSIVGOULIS, Georgios (300 Řecko); Duncan WILSON (826 Velká Británie a Severní Irsko); Aristeidis H. KATSANOS (300 Řecko); Joao SARGENTO-FREITAS (620 Portugalsko); Claudia MARQUES-MATOS (620 Portugalsko); Elsa AZEVEDO (620 Portugalsko); Tomohide ADACHI (392 Japonsko); Christian BRELIE (276 Německo); Yoshifusa AIZAWA (392 Japonsko); Hiroshi ABE (392 Japonsko); Hirofumi TOMITA (392 Japonsko); Ken OKUMURA (392 Japonsko); Joji HAGII (392 Japonsko); David J. SEIFFGE (756 Švýcarsko); Vasileios-Arsenios LIOUTAS (840 Spojené státy); Christopher TRAENKA (756 Švýcarsko); Panayiotis VARELAS (840 Spojené státy); Ghazala BASIR (124 Kanada); Christos KROGIAS (276 Německo); Jan C. PURRUCKER (276 Německo); Vijay K. SHARMA (702 Singapur); Timolaos RIZOS (276 Německo); Robert MIKULÍK (203 Česká republika, domácí); Oluwaseun A. SOBOWALE (826 Velká Británie a Severní Irsko); Kristian BARLINN (276 Německo); Hanne SALLINEN (246 Finsko); Nitin GOYAL (840 Spojené státy); Shin-Joe YEH (158 Tchaj-wan); Theodore KARAPANAYIOTIDES (300 Řecko); Teddy Y. WU (554 Nový Zéland); Konstantinos VADIKOLIAS (300 Řecko); Marc FERRIGNO (250 Francie); Georgios HADJIGEORGIOU (196 Kypr); Rik HOUBEN (528 Nizozemské království); Sotirios GIANNOPOULOS (300 Řecko); Floris H. B. M. SCHREUDER (528 Nizozemské království); Jason J. CHANG (840 Spojené státy); Luke A. PERRY (36 Austrálie); Maximilian MEHDORN (276 Německo); Joao-Pedro MARTO (620 Portugalsko); Joao PINHO (620 Portugalsko); Jun TANAKA (392 Japonsko); Marion BOULANGER (826 Velká Británie a Severní Irsko); Rustam Al-Shahi SALMAN (826 Velká Británie a Severní Irsko); Hans R. JAEGER (826 Velká Británie a Severní Irsko); Clare SHAKESHAFT (826 Velká Británie a Severní Irsko); Yusuke YAKUSHIJI (36 Austrálie); Philip M. C. CHOI (36 Austrálie); Julie STAALS (528 Nizozemské království); Charlotte CORDONNIER (250 Francie); Jiann-Shing JENG (158 Tchaj-wan); Roland VELTKAMP (826 Velká Británie a Severní Irsko); Dar DOWLATSHAHI (124 Kanada); Stefan T. ENGELTER (756 Švýcarsko); Adrian R. PARRY-JONES (826 Velká Británie a Severní Irsko); Atte MERETOJA (246 Finsko); Panayiotis D. MITSIAS (840 Spojené státy); Andrei V. ALEXANDROV (840 Spojené státy); Gareth AMBLER (826 Velká Británie a Severní Irsko) a David J. WERRING (826 Velká Británie a Severní Irsko, garant)

Vydání

Annals of neurology, Hoboken, John Wiley & Sons, 2018, 0364-5134

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30210 Clinical neurology

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 9.496

Kód RIV

RIV/00216224:14110/18:00105323

Organizační jednotka

Lékařská fakulta

DOI

https://doi.org/10.1002/ana.25342

UT WoS

000450819800007

EID Scopus

2-s2.0-85055512078

Klíčová slova anglicky

vitamin K antagonists; intracerebral hemorrhage

Štítky

14110127, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 10. 2. 2019 16:35, Soňa Böhmová

Anotace

V originále

Objective Methods Whether intracerebral hemorrhage (ICH) associated with non-vitamin K antagonist oral anticoagulants (NOAC-ICH) has a better outcome compared to ICH associated with vitamin K antagonists (VKA-ICH) is uncertain. We performed a systematic review and individual patient data meta-analysis of cohort studies comparing clinical and radiological outcomes between NOAC-ICH and VKA-ICH patients. The primary outcome measure was 30-day all-cause mortality. All outcomes were assessed in multivariate regression analyses adjusted for age, sex, ICH location, and intraventricular hemorrhage extension. Results Interpretation We included 7 eligible studies comprising 219 NOAC-ICH and 831 VKA-ICH patients (mean age = 77 years, 52.5% females). The 30-day mortality was similar between NOAC-ICH and VKA-ICH (24.3% vs 26.5%; hazard ratio = 0.94, 95% confidence interval [CI] = 0.67-1.31). However, in multivariate analyses adjusting for potential confounders, NOAC-ICH was associated with lower admission National Institutes of Health Stroke Scale (NIHSS) score (linear regression coefficient = -2.83, 95% CI = -5.28 to -0.38), lower likelihood of severe stroke (NIHSS > 10 points) on admission (odds ratio [OR] = 0.50, 95% CI = 0.30-0.84), and smaller baseline hematoma volume (linear regression coefficient = -0.24, 95% CI = -0.47 to -0.16). The two groups did not differ in the likelihood of baseline hematoma volume < 30cm(3) (OR = 1.14, 95% CI = 0.81-1.62), hematoma expansion (OR = 0.97, 95% CI = 0.63-1.48), in-hospital mortality (OR = 0.73, 95% CI = 0.49-1.11), functional status at discharge (common OR = 0.78, 95% CI = 0.57-1.07), or functional status at 3 months (common OR = 1.03, 95% CI = 0.75-1.43). Although functional outcome at discharge, 1 month, or 3 months was comparable after NOAC-ICH and VKA-ICH, patients with NOAC-ICH had smaller baseline hematoma volumes and less severe acute stroke syndromes. Ann Neurol 2018;84:702-712

Citovat

TSIVGOULIS, Georgios; Duncan WILSON; Aristeidis H. KATSANOS; Joao SARGENTO-FREITAS; Claudia MARQUES-MATOS; Elsa AZEVEDO; Tomohide ADACHI; Christian BRELIE; Yoshifusa AIZAWA; Hiroshi ABE; Hirofumi TOMITA; Ken OKUMURA; Joji HAGII; David J. SEIFFGE; Vasileios-Arsenios LIOUTAS; Christopher TRAENKA; Panayiotis VARELAS; Ghazala BASIR; Christos KROGIAS; Jan C. PURRUCKER; Vijay K. SHARMA; Timolaos RIZOS; Robert MIKULÍK; Oluwaseun A. SOBOWALE; Kristian BARLINN; Hanne SALLINEN; Nitin GOYAL; Shin-Joe YEH; Theodore KARAPANAYIOTIDES; Teddy Y. WU; Konstantinos VADIKOLIAS; Marc FERRIGNO; Georgios HADJIGEORGIOU; Rik HOUBEN; Sotirios GIANNOPOULOS; Floris H. B. M. SCHREUDER; Jason J. CHANG; Luke A. PERRY; Maximilian MEHDORN; Joao-Pedro MARTO; Joao PINHO; Jun TANAKA; Marion BOULANGER; Rustam Al-Shahi SALMAN; Hans R. JAEGER; Clare SHAKESHAFT; Yusuke YAKUSHIJI; Philip M. C. CHOI; Julie STAALS; Charlotte CORDONNIER; Jiann-Shing JENG; Roland VELTKAMP; Dar DOWLATSHAHI; Stefan T. ENGELTER; Adrian R. PARRY-JONES; Atte MERETOJA; Panayiotis D. MITSIAS; Andrei V. ALEXANDROV; Gareth AMBLER a David J. WERRING. Neuroimaging and clinical outcomes of oral anticoagulant-associated intracerebral hemorrhage. Annals of neurology. Hoboken: John Wiley & Sons, 2018, roč. 84, č. 5, s. 694-704. ISSN 0364-5134. Dostupné z: https://doi.org/10.1002/ana.25342.

@article{1484299,
   author = {Tsivgoulis, Georgios and Wilson, Duncan and Katsanos, Aristeidis H. and SargentoandFreitas, Joao and MarquesandMatos, Claudia and Azevedo, Elsa and Adachi, Tomohide and Brelie, Christian and Aizawa, Yoshifusa and Abe, Hiroshi and Tomita, Hirofumi and Okumura, Ken and Hagii, Joji and Seiffge, David J. and Lioutas, VasileiosandArsenios and Traenka, Christopher and Varelas, Panayiotis and Basir, Ghazala and Krogias, Christos and Purrucker, Jan C. and Sharma, Vijay K. and Rizos, Timolaos and Mikulík, Robert and Sobowale, Oluwaseun A. and Barlinn, Kristian and Sallinen, Hanne and Goyal, Nitin and Yeh, ShinandJoe and Karapanayiotides, Theodore and Wu, Teddy Y. and Vadikolias, Konstantinos and Ferrigno, Marc and Hadjigeorgiou, Georgios and Houben, Rik and Giannopoulos, Sotirios and Schreuder, Floris H. B. M. and Chang, Jason J. and Perry, Luke A. and Mehdorn, Maximilian and Marto, JoaoandPedro and Pinho, Joao and Tanaka, Jun and Boulanger, Marion and Salman, Rustam AlandShahi and Jaeger, Hans R. and Shakeshaft, Clare and Yakushiji, Yusuke and Choi, Philip M. C. and Staals, Julie and Cordonnier, Charlotte and Jeng, JiannandShing and Veltkamp, Roland and Dowlatshahi, Dar and Engelter, Stefan T. and ParryandJones, Adrian R. and Meretoja, Atte and Mitsias, Panayiotis D. and Alexandrov, Andrei V. and Ambler, Gareth and Werring, David J.},
   article_location = {Hoboken},
   article_number = {5},
   doi = {https://doi.org/10.1002/ana.25342},
   keywords = {vitamin K antagonists; intracerebral hemorrhage},
   language = {eng},
   issn = {0364-5134},
   journal = {Annals of neurology},
   title = {Neuroimaging and clinical outcomes of oral anticoagulant-associated intracerebral hemorrhage},
   volume = {84},
   year = {2018}
}

TY  - JOUR
ID  - 1484299
AU  - Tsivgoulis, Georgios - Wilson, Duncan - Katsanos, Aristeidis H. - Sargento-Freitas, Joao - Marques-Matos, Claudia - Azevedo, Elsa - Adachi, Tomohide - Brelie, Christian - Aizawa, Yoshifusa - Abe, Hiroshi - Tomita, Hirofumi - Okumura, Ken - Hagii, Joji - Seiffge, David J. - Lioutas, Vasileios-Arsenios - Traenka, Christopher - Varelas, Panayiotis - Basir, Ghazala - Krogias, Christos - Purrucker, Jan C. - Sharma, Vijay K. - Rizos, Timolaos - Mikulík, Robert - Sobowale, Oluwaseun A. - Barlinn, Kristian - Sallinen, Hanne - Goyal, Nitin - Yeh, Shin-Joe - Karapanayiotides, Theodore - Wu, Teddy Y. - Vadikolias, Konstantinos - Ferrigno, Marc - Hadjigeorgiou, Georgios - Houben, Rik - Giannopoulos, Sotirios - Schreuder, Floris H. B. M. - Chang, Jason J. - Perry, Luke A. - Mehdorn, Maximilian - Marto, Joao-Pedro - Pinho, Joao - Tanaka, Jun - Boulanger, Marion - Salman, Rustam Al-Shahi - Jaeger, Hans R. - Shakeshaft, Clare - Yakushiji, Yusuke - Choi, Philip M. C. - Staals, Julie - Cordonnier, Charlotte - Jeng, Jiann-Shing - Veltkamp, Roland - Dowlatshahi, Dar - Engelter, Stefan T. - Parry-Jones, Adrian R. - Meretoja, Atte - Mitsias, Panayiotis D. - Alexandrov, Andrei V. - Ambler, Gareth - Werring, David J.
PY  - 2018
TI  - Neuroimaging and clinical outcomes of oral anticoagulant-associated intracerebral hemorrhage
JF  - Annals of neurology
VL  - 84
IS  - 5
SP  - 694-704
EP  - 694-704
PB  - John Wiley & Sons
SN  - 03645134
KW  - vitamin K antagonists
KW  - intracerebral hemorrhage
N2  - Objective Methods Whether intracerebral hemorrhage (ICH) associated with non-vitamin K antagonist oral anticoagulants (NOAC-ICH) has a better outcome compared to ICH associated with vitamin K antagonists (VKA-ICH) is uncertain. We performed a systematic review and individual patient data meta-analysis of cohort studies comparing clinical and radiological outcomes between NOAC-ICH and VKA-ICH patients. The primary outcome measure was 30-day all-cause mortality. All outcomes were assessed in multivariate regression analyses adjusted for age, sex, ICH location, and intraventricular hemorrhage extension. Results Interpretation We included 7 eligible studies comprising 219 NOAC-ICH and 831 VKA-ICH patients (mean age = 77 years, 52.5% females). The 30-day mortality was similar between NOAC-ICH and VKA-ICH (24.3% vs 26.5%; hazard ratio = 0.94, 95% confidence interval [CI] = 0.67-1.31). However, in multivariate analyses adjusting for potential confounders, NOAC-ICH was associated with lower admission National Institutes of Health Stroke Scale (NIHSS) score (linear regression coefficient = -2.83, 95% CI = -5.28 to -0.38), lower likelihood of severe stroke (NIHSS > 10 points) on admission (odds ratio [OR] = 0.50, 95% CI = 0.30-0.84), and smaller baseline hematoma volume (linear regression coefficient = -0.24, 95% CI = -0.47 to -0.16). The two groups did not differ in the likelihood of baseline hematoma volume < 30cm(3) (OR = 1.14, 95% CI = 0.81-1.62), hematoma expansion (OR = 0.97, 95% CI = 0.63-1.48), in-hospital mortality (OR = 0.73, 95% CI = 0.49-1.11), functional status at discharge (common OR = 0.78, 95% CI = 0.57-1.07), or functional status at 3 months (common OR = 1.03, 95% CI = 0.75-1.43). Although functional outcome at discharge, 1 month, or 3 months was comparable after NOAC-ICH and VKA-ICH, patients with NOAC-ICH had smaller baseline hematoma volumes and less severe acute stroke syndromes. Ann Neurol 2018;84:702-712
ER  -

TSIVGOULIS, Georgios; Duncan WILSON; Aristeidis H. KATSANOS; Joao SARGENTO-FREITAS; Claudia MARQUES-MATOS; Elsa AZEVEDO; Tomohide ADACHI; Christian BRELIE; Yoshifusa AIZAWA; Hiroshi ABE; Hirofumi TOMITA; Ken OKUMURA; Joji HAGII; David J. SEIFFGE; Vasileios-Arsenios LIOUTAS; Christopher TRAENKA; Panayiotis VARELAS; Ghazala BASIR; Christos KROGIAS; Jan C. PURRUCKER; Vijay K. SHARMA; Timolaos RIZOS; Robert MIKULÍK; Oluwaseun A. SOBOWALE; Kristian BARLINN; Hanne SALLINEN; Nitin GOYAL; Shin-Joe YEH; Theodore KARAPANAYIOTIDES; Teddy Y. WU; Konstantinos VADIKOLIAS; Marc FERRIGNO; Georgios HADJIGEORGIOU; Rik HOUBEN; Sotirios GIANNOPOULOS; Floris H. B. M. SCHREUDER; Jason J. CHANG; Luke A. PERRY; Maximilian MEHDORN; Joao-Pedro MARTO; Joao PINHO; Jun TANAKA; Marion BOULANGER; Rustam Al-Shahi SALMAN; Hans R. JAEGER; Clare SHAKESHAFT; Yusuke YAKUSHIJI; Philip M. C. CHOI; Julie STAALS; Charlotte CORDONNIER; Jiann-Shing JENG; Roland VELTKAMP; Dar DOWLATSHAHI; Stefan T. ENGELTER; Adrian R. PARRY-JONES; Atte MERETOJA; Panayiotis D. MITSIAS; Andrei V. ALEXANDROV; Gareth AMBLER a David J. WERRING. Neuroimaging and clinical outcomes of oral anticoagulant-associated intracerebral hemorrhage. \textit{Annals of neurology}. Hoboken: John Wiley \&{} Sons, 2018, roč.~84, č.~5, s.~694-704. ISSN~0364-5134. Dostupné z: https://doi.org/10.1002/ana.25342.

Přehled o publikaci